Auxly Cannabis Group Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a XLY.TO research report →
Price Chart
About the company
Auxly Cannabis Group Inc. operates as a Canadian consumer packaged goods (CPG) firm focused on the cannabis market. Its primary activities include the development, manufacturing, and distribution of cannabis products, targeting both recreational and wellness consumers.
- CEO
- Hugo Alves
- IPO
- 2018
- Employees
- 446
- HQ
- Toronto, ON, CA
Get TickerSpark's AI analysis on XLY.TO
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $318.17M
- P/E
- 9.43
- Fwd P/E
- 14.95
- PEG
- 0.94
- P/S
- 1.92
- P/B
- 1.73
- EV/EBITDA
- 9.54
- Div Yield
- 0.00%
- Gross Margin
- 37.91%
- Op Margin
- 4.52%
- Net Margin
- 19.69%
- ROE
- 18.12%
- ROIC
- 3.13%
Latest fiscal year · YoY change
- Revenue
- $151.48M+23.8%
- Gross Profit
- $86.74M+44.7%
- Op Income
- $32.67M
- Net Income
- $41.85M+356.0%
- EPS
- $0.44+331.6%
- OCF Growth
- +54.3%
- FCF Growth
- +66.8%
- 52W High
- $3.30
- 52W Low
- $1.54
- 50D MA
- $2.61
- 200D MA
- $2.12
- Beta
- 1.19
- RSI (14)
- 64
- Avg Volume
- 92.32K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Auxly delivered record Q2 results with stronger revenue, EBITDA, and cash flow, while keeping its 2026 outlook unchanged and signaling further investment in Leamington and share buybacks.· August 13, 2026
- Net revenue was a quarterly record at 45.8 million, up 18% year over year, driven by Back Forty strength in flower, pre-rolls, and vapes.
- Adjusted EBITDA reached 14.3 million, up 24% year over year, with a 31% margin for the quarter.
- Gross margin on finished cannabis inventory sold improved to 55% from 52% in Q2 25, and cash flow from operations before working capital changes was 13.4 million, up 31% year over year.
- Management said 2026 guidance is unchanged and still expects net revenue growth above market rates, supported by distribution, innovation, and added quality/capacity at Auxly Leamington.
- Capital allocation remains a mix of organic reinvestment, NCIB repurchases, and a planned roughly 30 million Leamington expansion over 3 years, including 10 million to 12 million previously guided for 2026.
Auxly reported Q2 26 net revenue of 45.8 million, up 18% year over year; gross margin on finished cannabis inventory sold of 55%, up from 52% in Q2 25; adjusted EBITDA of 14.3 million, up 24% year over year, with a 31% EBITDA margin; and cash flow from operations before working capital changes of 13.4 million, up 31% year over year. Management also said quarterly net income was 7.7 million, essentially flat versus 8.3 million in Q2 25, and that cash on hand was 38 million versus 44 million of long-term debt. Forward-looking, management left its 2026 outlook unchanged, expecting net revenue growth above market rates, improved cash conversion, and continued profitability, while outlining a roughly 30 million capital program over 3 years to raise Leamington yield by about 30% over 2025 levels, including 10 million to 12 million in 2026.
Hugo Alves emphasized that the quarter showed structural operating leverage, calling out record revenue, EBITDA, and cash flow as proof that Auxly’s scale and cost discipline are working. He framed the growth strategy around innovation, distribution, and expanding capacity at Leamington, and said the company is prioritizing Canada over international markets for now because it sees the highest-return opportunity at home. His tone was confident and constructive, with repeated comments that demand remains very strong and that the business is building long-term value.
Travis Wong focused on the durability of the margin structure, saying the 31% EBITDA margin is supported by three main levers: stronger net revenue, structurally higher gross margin, and controlled SG&A growth. He pointed to higher cultivation yields, improved manufacturing at Leamington and Charlottetown, and strategic procurement efforts such as lower vape API costs as drivers of the gross margin improvement to 55%. He also noted that net income was 7.7 million and said underlying net income would have improved meaningfully excluding noncash fair value adjustments, while cash flow conversion from adjusted EBITDA was 94% and the company ended with 38 million in cash and 44 million in long-term debt.
Analysts asked about the planned 30% yield increase in Leamington, and management said it will come from additional post-harvest capabilities, a new grow zone, and related infrastructure, with improvements expected throughout the 3-year buildout. Questions on margin sustainability led Travis Wong to say the company believes the EBITDA margin is sustainable because gross margin gains are structural and SG&A is being kept in line with revenue growth. On international expansion, Hugo Alves said Auxly sees long-term potential but is not rushing, preferring to focus on winning in Canada while maintaining optionality through Imperial Brands and market learning.
The call presented a business with record quarterly revenue, EBITDA, and operating cash flow, plus a 55% gross margin and 31% EBITDA margin that management believes are structural rather than one-off. Management also sounded confident that innovation is working, demand remains strong, and Leamington expansion could support additional growth over the next several years.
The main risks discussed were execution on the multi-year Leamington expansion, which depends on capital spending and operational progress through 2028, and the fact that cannabis international markets remain uncertain and fast-changing. Management also acknowledged that SG&A will need to rise as the business scales, and that share repurchases become less attractive if the stock price increases.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 76.5%
- Shares Outstanding
- 101.33M
- Float Shares
- 77.51M
Our XLY.TO coverage
Recent articles, reports, and earnings notes.
No research on XLY.TO yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate XLY.TO report →Auxly Announces Results of Annual General and Special Meeting of Shareholders
gurufocus.com · Jul 2
Auxly Cannabis Group to Present at the Small Cap Growth Virtual Investor Conference December 9th
globenewswire.com · Dec 4
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.